The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats

S. Charntikov, A. M. Falco, K. Fink, L. P. Dwoskin, Rick A Bevins

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Nicotine is the primary addictive component of tobacco products and its complex stimulus effects are readily discriminated by human and non-human animals. Previous research with rodents directly investigating the nature of the nicotine stimulus has been limited to males. The current study began to address this significant gap in the literature by training female and male rats to discriminate 0.4 mg/kg nicotine from saline in the discriminated goal-tracking task. In this task, access to sucrose was intermittently available on nicotine session. On interspersed saline session, sucrose was not available. Both sexes acquired the discrimination as evidenced by increased head entries into sucrose receptacle (goal-tracking) evoked by nicotine; the nicotine generalization curves were also similar between females and males. The pharmacological profile of the nicotine stimulus was assessed using substitution and targeted combination tests with the following ligands: sazetidine-A, PHA-543613, PNU-120596, bupropion, nornicotine, and cytisine. For females and males, nornicotine fully substituted for the nicotine stimulus, whereas sazetidine-A, bupropion, and cytisine all evoked partial substitution. Female and male rats responded in a similar manner to interaction tests where a combination of 1 mg/kg of sazetidine-A plus nicotine or nornicotine shifted the nicotine dose-effect curve to the left. The combination of sazetidine-A plus bupropion or cytisine failed to do so. These findings begin to fill a significant gap the in scientific literature by studying the nature of the nicotine stimulus and response to therapeutically interesting combinations using a model that includes both sexes.

Original languageEnglish (US)
Pages (from-to)354-366
Number of pages13
JournalNeuropharmacology
Volume113
DOIs
StatePublished - Feb 1 2017

Fingerprint

Nicotine
Ligands
nornicotine
Bupropion
Sucrose
sazetidine-A
Literature
Sexism
Tobacco Products
Rodentia
Head
Pharmacology

Keywords

  • Acetylcholine
  • Drug discrimination
  • Interoceptive stimulus
  • Nicotine dependence
  • Pavlovian conditioning
  • Smoking
  • Tobacco

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats. / Charntikov, S.; Falco, A. M.; Fink, K.; Dwoskin, L. P.; Bevins, Rick A.

In: Neuropharmacology, Vol. 113, 01.02.2017, p. 354-366.

Research output: Contribution to journalArticle

@article{0dcce9e8d9a349adb6326a5c55ebf5f6,
title = "The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats",
abstract = "Nicotine is the primary addictive component of tobacco products and its complex stimulus effects are readily discriminated by human and non-human animals. Previous research with rodents directly investigating the nature of the nicotine stimulus has been limited to males. The current study began to address this significant gap in the literature by training female and male rats to discriminate 0.4 mg/kg nicotine from saline in the discriminated goal-tracking task. In this task, access to sucrose was intermittently available on nicotine session. On interspersed saline session, sucrose was not available. Both sexes acquired the discrimination as evidenced by increased head entries into sucrose receptacle (goal-tracking) evoked by nicotine; the nicotine generalization curves were also similar between females and males. The pharmacological profile of the nicotine stimulus was assessed using substitution and targeted combination tests with the following ligands: sazetidine-A, PHA-543613, PNU-120596, bupropion, nornicotine, and cytisine. For females and males, nornicotine fully substituted for the nicotine stimulus, whereas sazetidine-A, bupropion, and cytisine all evoked partial substitution. Female and male rats responded in a similar manner to interaction tests where a combination of 1 mg/kg of sazetidine-A plus nicotine or nornicotine shifted the nicotine dose-effect curve to the left. The combination of sazetidine-A plus bupropion or cytisine failed to do so. These findings begin to fill a significant gap the in scientific literature by studying the nature of the nicotine stimulus and response to therapeutically interesting combinations using a model that includes both sexes.",
keywords = "Acetylcholine, Drug discrimination, Interoceptive stimulus, Nicotine dependence, Pavlovian conditioning, Smoking, Tobacco",
author = "S. Charntikov and Falco, {A. M.} and K. Fink and Dwoskin, {L. P.} and Bevins, {Rick A}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.neuropharm.2016.10.014",
language = "English (US)",
volume = "113",
pages = "354--366",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats

AU - Charntikov, S.

AU - Falco, A. M.

AU - Fink, K.

AU - Dwoskin, L. P.

AU - Bevins, Rick A

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Nicotine is the primary addictive component of tobacco products and its complex stimulus effects are readily discriminated by human and non-human animals. Previous research with rodents directly investigating the nature of the nicotine stimulus has been limited to males. The current study began to address this significant gap in the literature by training female and male rats to discriminate 0.4 mg/kg nicotine from saline in the discriminated goal-tracking task. In this task, access to sucrose was intermittently available on nicotine session. On interspersed saline session, sucrose was not available. Both sexes acquired the discrimination as evidenced by increased head entries into sucrose receptacle (goal-tracking) evoked by nicotine; the nicotine generalization curves were also similar between females and males. The pharmacological profile of the nicotine stimulus was assessed using substitution and targeted combination tests with the following ligands: sazetidine-A, PHA-543613, PNU-120596, bupropion, nornicotine, and cytisine. For females and males, nornicotine fully substituted for the nicotine stimulus, whereas sazetidine-A, bupropion, and cytisine all evoked partial substitution. Female and male rats responded in a similar manner to interaction tests where a combination of 1 mg/kg of sazetidine-A plus nicotine or nornicotine shifted the nicotine dose-effect curve to the left. The combination of sazetidine-A plus bupropion or cytisine failed to do so. These findings begin to fill a significant gap the in scientific literature by studying the nature of the nicotine stimulus and response to therapeutically interesting combinations using a model that includes both sexes.

AB - Nicotine is the primary addictive component of tobacco products and its complex stimulus effects are readily discriminated by human and non-human animals. Previous research with rodents directly investigating the nature of the nicotine stimulus has been limited to males. The current study began to address this significant gap in the literature by training female and male rats to discriminate 0.4 mg/kg nicotine from saline in the discriminated goal-tracking task. In this task, access to sucrose was intermittently available on nicotine session. On interspersed saline session, sucrose was not available. Both sexes acquired the discrimination as evidenced by increased head entries into sucrose receptacle (goal-tracking) evoked by nicotine; the nicotine generalization curves were also similar between females and males. The pharmacological profile of the nicotine stimulus was assessed using substitution and targeted combination tests with the following ligands: sazetidine-A, PHA-543613, PNU-120596, bupropion, nornicotine, and cytisine. For females and males, nornicotine fully substituted for the nicotine stimulus, whereas sazetidine-A, bupropion, and cytisine all evoked partial substitution. Female and male rats responded in a similar manner to interaction tests where a combination of 1 mg/kg of sazetidine-A plus nicotine or nornicotine shifted the nicotine dose-effect curve to the left. The combination of sazetidine-A plus bupropion or cytisine failed to do so. These findings begin to fill a significant gap the in scientific literature by studying the nature of the nicotine stimulus and response to therapeutically interesting combinations using a model that includes both sexes.

KW - Acetylcholine

KW - Drug discrimination

KW - Interoceptive stimulus

KW - Nicotine dependence

KW - Pavlovian conditioning

KW - Smoking

KW - Tobacco

UR - http://www.scopus.com/inward/record.url?scp=84992580493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992580493&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2016.10.014

DO - 10.1016/j.neuropharm.2016.10.014

M3 - Article

C2 - 27765626

AN - SCOPUS:84992580493

VL - 113

SP - 354

EP - 366

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -